Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-64.47M
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-70.07M
Historical baseline
PeriodValueYoY Change
2025$-64.47M-24.7%
2024$-51.72M+55.2%
2023$-115.45M-36.9%
2022$-84.36M-30.9%
2021$-64.46M-36.6%
2020$-47.20M+47.7%
2019$-90.23M-11.7%
2018$-80.78M-51.1%
2017$-53.45M-10.1%
2016$-48.57M-